Skip to main content
Bohn Stafleu van Loghum
ZOEKEN
MENU 1 2 3 4
main-content
Top

Tip

Swipe om te navigeren naar een ander artikel

Gepubliceerd in: Quality of Life Research 8/2010

01-10-2010 | Brief Communication

Quality of life of patients with oesophageal cancer in Taiwan: validation and application of the Taiwan Chinese (Mandarin) version of the EORTC QLQ-OES18: a brief communication

Auteurs: Wei-Chu Chie, Chia-Jih Tsai, Chieh Chiang, Yung-Chie Lee

Gepubliceerd in: Quality of Life Research | Uitgave 8/2010

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

Purpose

The aim of this study was to examine the reliability and validity, and the application of the Taiwan Chinese Version of the EORTC QLQ-OES18.

Methods

The authors translated the questionnaire according to the guideline of the EORTC. Ninety-five patients with oesophageal cancer in National Taiwan University Hospital were interviewed using the questionnaire and the EORTC QLQ-C30 between October 2002 and September 2007. Answer distribution and psychometric properties of the EORTC QLQ-OES18 were examined.

Results

The mean age of the patients was 60 years (SD 12 years). Most of the patients were in advanced stages of disease, with two-thirds off-treatment. The Cronbach’s alpha coefficients were satisfactory (0.77–0.82) or near-satisfactory (pain: 0.67). The item-to-own and item-to-other scale correlations showed satisfactory results. Patients who were on-treatment versus off-treatment had significantly poorer quality of life scores in dysphagia, dry mouth, and taste, and a borderline poorer score in cough. Opposite situations were seen in the scales of reflux and choking.

Conclusions

The EORTC QLQ-OES18 is a valid instrument to assess quality of life issues in patients with oesophageal cancer in Taiwan.
vorige artikel Erratum to: Gender differences in health-related quality-of-life are partly explained by sociodemographic and socioeconomic variation between adult men and women in the US: evidence from four US nationally representative data sets
volgende artikel Quality of life, subjective well-being, and religiosity in Muslim college students
Literatuur
1.
2.
3.
Akiyama, H., Tsurumaru, M., Udagawa, H., & Kajiyama, Y. (1997). Oesophageal cancer. Current Problems in Surgery, 34, 765–834. CrossRefPubMed
4.
Hulscher, J. B., van Sandick, J. W., de Boer, A. G., Wijnhoven, B. P. L., Tijssen, J. G. P., Fockens, P., et al. (2002). Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. New England Journal of Medicine, 347, 1662–1669. CrossRefPubMed
5.
Cunningham, D., Starling, N., Rao, S., Iveson, T., Nicolson, M., Coxon, F., et al. (2008). Capecitabine and oxaliplatin for advanced esophagogastric cancer. New England Journal of Medicine, 358, 36–46. CrossRefPubMed
6.
Aaronson, N. K., Ahmedzai, A., Berman, B., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85, 65–376.
7.
Apolone, G., Filiberti, A., Cifani, S., Ruggiata, R., & Mosconi, P. (1998). Evaluation of the EORTC QLQ-C30 questionnaire: a comparison with SF-36 Health Survey in a cohort of Italian long-survival cancer patients. Annals of Oncology, 9, 549–557. CrossRefPubMed
8.
McLachlan, S.-A., Devins, G. M., & Goodwin, P. J. (1998). Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (QLQ-C30) as a measure of psychosocial function in breast cancer patients. European J Cancer, 34, 510–517. CrossRef
9.
McLachlan, S. A., Devins, G. M., & Goodwin, P. J. (1999). Factor analysis of the psychosocial items of the EORTC QLQ-C30 in metastatic breast cancer patients participating in a psychosocial intervention study. Quality of Life Research, 8, 311–317. CrossRefPubMed
10.
Hjermstad, M. J., Fossa, S. D., Bjordal, K., & Kaasa, S. (1995). Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire. J Clin Oncology, 13, 1249–1254.
11.
Groenvold, M., Klee, M. C., Sprangers, M. A. G., & Aaronson, N. K. (1997). Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement. Journal of Clinical Epidemiology, 50, 441–450. CrossRefPubMed
12.
Chie, W. C., Hong, R. L., Lai, C. C., Ting, L. L., & Hsu, M. M. (2003). Quality of Life in Patients of Nasopharyngeal Carcinoma: Validation of the Taiwan Chinese version of the EORTC QLQ-C30 and the EORTC QLQ-H&N35. Quality of Life Research, 12, 93–98. CrossRefPubMed
13.
Chie, W. C., Chang, K. J., Huang, C. S., & Kuo, W. H. (2003). Quality of life of breast cancer patients in Taiwan: validation of the Taiwan Chinese version of the EORTC QLQ-C30 and EORTC QLQ-BR23. Psycho-Oncology, 12, 729–735. CrossRefPubMed
14.
Chie, W. C., Yang, C. H., Hsu, C., & Yang, P. C. (2004). Quality of life of lung cancer patients: validation of the Taiwan Chinese version of the EORTC QLQ-C30 and QLQ-LC13. Quality of Life Research, 13, 257–262. CrossRefPubMed
15.
Huang, C. C., Lien, H. H., Sung, Y. C., Liu, H. T., & Chie, W. C. (2007). Quality of life of patients with gastric cancer in Taiwan: Validation and clinical application of the Taiwan Chinese version of the EORTC QLQ-C30 and EORTC QLQ-STO22. Psycho-Oncology, 16, 945–949. CrossRefPubMed
16.
Blazeby, J. M., Alderson, D., Winstone, K., Steyn, R., Hammerlid, E., Arraras, J., et al. (1996). Development of an EORTC questionnaire module to be in quality of life assessment for patients with oesophageal cancer. European Journal of Cancer, 32A, 1912–1917. CrossRefPubMed
17.
Blazeby, J. M., Conroy, T., Hammerlid, E., Fayers, P., Sezer, O., Koller, M., et al. (2003). Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer. European Journal of Cancer, 39, 1384–1394. CrossRefPubMed
18.
Blazeby, J. M., Farndon, J. R., Donovan, J., & Alderson, D. (2000). A prospective longitudinal study examining the quality of life of patients with esophageal cancer. Cancer, 88, 1781–1787. CrossRefPubMed
19.
Lagergren, P., Avery, K. N., Hughes, R., Barham, C. P., Alderson, D., Falk, S. J., et al. (2007). Health-related quality of life among patients cured by surgery for esophageal cancer. Cancer, 110, 686–693. CrossRefPubMed
20.
Martin, L., Lagergren, J., Lindblad, M., Rouvelas, I., & Lagergren, P. (2007). Malnutrition after oesophageal cancer surgery in Sweden. British Journal of Surgery, 94, 1496–1500. CrossRefPubMed
21.
Bergquist, H., Johnsson, A., Hammerlid, E., Wenger, U., Lundell, L., & Ruth, M. (2008). Factors predicting survival in patients with advanced oesophageal cancer: A prospective multicentre evaluation. Alimentary Pharmacology & Therapeutics, 27, 385–395. CrossRef
22.
Djärv, T., Blazeby, J. M., & Lagergren, P. (2009). Predictors of postoperative quality of life after esophagectomy for cancer. Journal of Clinical Oncology, 27, 1963–1968. CrossRefPubMed
23.
Cull, A., Sprangers, M., Bjordal, K., et al. (1998). EORTC quality of life study group translation procedure. Brussels: EORTC Quality of Life Study Group.
24.
Tabachnik, B. G., & Fidell, L. S. (2001). Using multivariate statistics. London: Harper & Row.
25.
Osoba, D., Rodrigues, G., Myles, J., Zee, B., & Pater, J. (1998). Interpreting the significance of changes in health-related quality of life scores. Journal of Clinical Oncology, 16, 139–144. PubMed
26.
Fayers, P., Aaronson, N., Bjordal, K., Curran, D., & Groenvold, M. (1999). EORTC QLQ-C30 scoring manual (2nd ed.). Brussels: EORTC Quality of Life Study Group.
27.
Blazeby, J. M., Conroy, T., Bottomley, A., Vickery, C., Arraras, J., Sezer, O., Moore, J., Koller, M., Turhal, N. S., Stuart, R., Van Cutsem, E., D’haese, S., Coens, C., European Organisation for Research and Treatment of Cancer Gastrointestinal and Quality of Life Groups. (2004). Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO22, to assess quality of life in patients with gastric cancer. Eur J Cancer, 40, 2260–2268.
28.
Lagergren, P., Fayers, P., Conroy, T., Stein, H. J., Sezer, O., Hardwick, R., Hammerlid, E., Bottomley, A., Van Cutsem, E., Blazeby, J. M., and on behalf of the European Organisation for Research Treatment of Cancer Gastrointestinal and Quality of Life Group. (2007). Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-OG25, to assess health-related quality of life in patients with cancer of the oesophagus, the oesophago–gastric junction and the stomach. European Journal of Cancer, 43, 2066–2073.
Metagegevens
Titel
Quality of life of patients with oesophageal cancer in Taiwan: validation and application of the Taiwan Chinese (Mandarin) version of the EORTC QLQ-OES18: a brief communication
Auteurs
Wei-Chu Chie
Chia-Jih Tsai
Chieh Chiang
Yung-Chie Lee
Publicatiedatum
01-10-2010
Uitgeverij
Springer Netherlands
Gepubliceerd in
Quality of Life Research / Uitgave 8/2010
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-010-9675-8

Andere artikelen Uitgave 8/2010

Quality of Life Research 8/2010 Naar de uitgave

OriginalPaper

Psychometric evaluation of the functional assessment of HIV Infection (FAHI) questionnaire and its usefulness in clinical trials

OriginalPaper

PRO development: rigorous qualitative research as the crucial foundation

OriginalPaper

Interference with activities due to pain and fatigue: accuracy of ratings across different reporting periods

OriginalPaper

Preliminary findings of an investigation into the relationship between national culture and EQ-5D value sets

OriginalPaper

The impact of next and back buttons on time to complete and measurement reliability in computer-based surveys

OriginalPaper

Invariance test of the Multidimensional Body Self-Relations Questionnaire: do women with breast cancer interpret this measure differently?

Version: 0.2164.0